Avance Clinical to Present Early Phase Trial Model at AusBiotech Conference

Avance Clinical, a global contract research organization (CRO) specializing in early phase and First-in-Human trials, will exhibit at the AusBiotech International Conference 2026 in Gold Coast from October 21-23, 2026. The company, headquartered in Australia, will present its Early Phase Center of Excellence model designed to enhance the execution of early-stage clinical trials for biotechnology firms.

The conference brings together biotechnology professionals from around the world, and Avance Clinical views it as a key platform to introduce its approach. With over 30 years of experience in early phase research in Australia and New Zealand, the company has partnered with numerous biotech firms. Avance Clinical notes that sponsors increasingly seek faster data readouts and reduced execution risk across the entire Phase I to Phase II development arc.

The company's Center of Excellence model is an integrated operating model aiming to seamlessly combine design, delivery, and regulatory strategy. This approach aims to overcome the fragmented models common in the sector, where separate teams often manage distinct phases. Avance Clinical asserts that this integrated model shortens cycle times, which is crucial for venture-backed biotechs as it extends cash runway and strengthens their negotiating position with investors.

Additionally, Avance Clinical has appointed Cameron White to the newly created role of Director of Operational Strategy, Early Phase Center of Excellence. He will be responsible for the model's planning, strategic development, and execution across the company's global network. Avance Clinical invites interested sponsors to discuss their early phase trial strategies at Booth #72.